| |
Company
Roster
|
|
Total
Insiders : |
69 |
|
|
|
Total
Direct Shares :
|
16,320,141 |
|
|
Total
Indirect Shares :
|
96,401,907 |
| |
%
Held by Insiders:
|
4.8% |
|
|
| |
| Filer's Name |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
  Campbell Bradley L |
|
2025-03-15 |
1,137,282 |
2014-04-10 |
0 |
| Prout Samantha |
|
2025-02-11 |
109,441 |
2019-01-02 |
0 |
| Castelli Jeff |
|
2025-02-11 |
465,476 |
2014-04-10 |
0 |
| Clark David Michael |
|
2025-02-11 |
348,261 |
2018-10-09 |
0 |
| Rosenberg Ellen |
|
2025-02-11 |
507,710 |
2025-02-11 |
15,000 |
| Harford Simon N.r. |
|
2025-01-03 |
227,427 |
2023-08-21 |
0 |
| Roberts Eiry |
|
2024-06-06 |
55,861 |
2021-06-10 |
0 |
| Mcglynn Margaret G |
|
2024-06-06 |
71,136 |
2015-11-10 |
0 |
| Kelly Michael Aaron |
|
2024-06-06 |
52,054 |
2020-12-01 |
0 |
| Bleil Lynn Dorsey |
|
2024-06-06 |
93,527 |
2018-09-07 |
0 |
| Whitman Burke W |
|
2024-06-06 |
98,184 |
2019-06-27 |
0 |
| Raab Michael |
|
2024-06-06 |
95,443 |
2015-06-08 |
0 |
| Wheeler Craig A |
|
2024-06-06 |
64,217 |
2017-06-13 |
0 |
| Sblendorio Glenn |
|
2024-06-06 |
95,443 |
|
0 |
| Crowley John F |
|
2024-03-01 |
573,478 |
2024-03-01 |
64,895 |
| Quimi Daphne |
Chief Financial Officer |
2023-01-18 |
398,532 |
2014-04-10 |
0 |
| Essner Robert |
Director |
2021-06-10 |
31,115 |
2017-06-13 |
0 |
| Do Hung |
Chief Science Officer |
2021-04-06 |
448,617 |
|
0 |
| Barth Jay |
Chief Medical Officer |
2020-09-30 |
163,204 |
2020-09-30 |
20 |
| Love Ted W |
Director |
2020-06-04 |
131,000 |
2014-03-12 |
0 |
| Baird William D Iii |
Chief Financial Officer |
2018-10-15 |
117,622 |
2014-04-10 |
0 |
| Andrews Kurt J. |
SVP, Human Resources |
2018-07-02 |
35,469 |
2016-06-15 |
0 |
| Hayden Donald J Jr |
Director |
2018-06-07 |
8,895 |
2015-06-23 |
0 |
| Green Jeremy |
10% Owner |
2016-06-03 |
0 |
2016-06-03 |
12,956,446 |
| Peist Kenneth |
VP, Legal & IP |
2016-01-04 |
18,874 |
2011-01-03 |
250 |
| Valenzano Ken |
SVP, Pharmacology & Biology |
2015-07-13 |
27,687 |
|
0 |
| Doshi Dipal |
SVP Strategy & Bus Dev |
2015-07-08 |
1,706 |
2014-07-07 |
0 |
| Gershkowitz Jayne |
SVP, Chief Patient Advocate |
2015-07-01 |
5,693 |
2014-04-10 |
0 |
| Dilone Enrique |
SVP, Technical Operations |
2015-06-19 |
30,688 |
2014-04-10 |
0 |
| Yu Julie |
VP Clinical Ops & Data Mgmt |
2015-06-15 |
0 |
2014-04-10 |
0 |
| Baldry Mark |
VP Global Marketing |
2015-06-01 |
25,000 |
2015-06-01 |
0 |
| Kirk John |
VP, Regulatory Affairs |
2015-05-11 |
5,687 |
2014-04-10 |
0 |
| David Allsop |
SVP International |
2015-04-27 |
50,000 |
2015-04-27 |
0 |
| Perceptive Life Sciences Master Fund Ltd |
10% Owner |
2014-06-30 |
0 |
2016-12-30 |
16,293,847 |
| Barer Sol J |
Director |
2013-03-15 |
45,000 |
2009-11-04 |
0 |
| Winterbottom Joan |
SVP, Human Resources |
2012-11-13 |
1,665 |
2012-11-13 |
0 |
| Barrett M James |
Director, 10% Owner |
2012-03-07 |
0 |
2012-03-07 |
4,584,311 |
| Patterson Matthew R |
Acting CEO & President |
2011-04-18 |
106,547 |
|
0 |
| Dentzer James E |
Chief Financial Officer |
2009-10-01 |
32,075 |
|
0 |
| Palling David |
Sr VP, Technical Operations |
2009-06-29 |
34,040 |
2007-05-30 |
6,666 |
| Licholai Gregory P |
VP, Medical Affairs |
2008-08-18 |
152 |
2007-05-30 |
6,666 |
| Schaeffer Orlov S Nicole |
Sr. VP, HR & Lead.Devlop. |
2008-08-13 |
12,582 |
|
0 |
| Fhm V, Lp |
10% Owner |
2008-01-31 |
0 |
2008-01-31 |
281,515 |
| Fhm V, Llc |
10% Owner |
2007-07-25 |
0 |
2008-02-05 |
3,097,904 |
| Frazier Healthcare Iv Lp |
10% Owner |
2007-06-28 |
0 |
2007-06-29 |
2,767,329 |
| Chl Medical Partners Ii, L.p. |
10% Owner |
2007-06-05 |
1,975,456 |
2007-06-05 |
2,108,554 |
| Frazier Affiliates Iv Lp |
10% Owner |
2007-06-05 |
0 |
2008-03-10 |
3,520,678 |
| Young Eric A |
10% Owner |
2007-06-05 |
0 |
2007-06-05 |
2,050,790 |
| Neff Sherrill P |
Director |
2007-06-05 |
0 |
2007-06-05 |
1,419,762 |
| Newhall Charles W III |
10% Owner |
2007-06-05 |
0 |
2012-03-07 |
4,584,311 |
| Chl Medical Partners Ii Side Fund, L.p. |
10% Owner |
2007-06-05 |
2,108,555 |
2007-06-05 |
1,975,456 |
| Topper James N |
Director, 10% Owner |
2007-06-05 |
0 |
2008-03-10 |
3,520,678 |
| Bloch Stephen M |
Director |
2007-06-05 |
0 |
2009-02-11 |
61,700 |
| Barkas Alexander E |
Director |
2007-06-05 |
0 |
2007-06-05 |
33,608 |
| Kramlich C Richard |
10% Owner |
2007-06-05 |
0 |
2012-03-07 |
4,584,311 |
| Quaker Bio Ventures Lp |
10% Owner |
2007-06-05 |
1,064,822 |
2007-06-05 |
1,419,762 |
| Trainor III Eugene A |
10% Owner |
2007-06-05 |
3,659,157 |
2007-06-05 |
0 |
| Hirsch Russell C |
10% Owner |
2007-06-05 |
0 |
2007-06-05 |
33,608 |
| Barris Peter J |
10% Owner |
2007-06-05 |
0 |
2007-07-25 |
4,510,340 |
| Garden State Life Sciences Venture Fund L P |
10% Owner |
2007-06-05 |
1,419,762 |
2007-06-05 |
1,064,822 |
| Perry Mark W |
10% Owner |
2007-06-05 |
0 |
2012-03-07 |
4,584,311 |
| Mount Sinai School Of Medicine Of New York Univers |
10% Owner |
2007-05-30 |
365,599 |
|
0 |
| Winkler Robert E |
|
|
0 |
|
0 |
| Edelman Joseph |
10% Owner |
|
0 |
2018-10-03 |
20,724,424 |
| Glaxosmithkline Plc |
Former 10% Owner (1) |
|
0 |
2014-10-27 |
0 |
| Lockhart David J |
|
|
0 |
|
0 |
| Weinhoff Gregory M |
Director |
|
0 |
2008-08-14 |
129,943 |
| Boudes Pol F |
|
|
0 |
|
0 |
| Macaluso Peter M |
|
|
0 |
|
0 |
|
0.28 (2.71%) 
